The Covid-19 pandemic and the accompanying race for new drugs is the main cause for an expected 21 % annual growth rate in the global CRISPR technology market. According to a new market report from The Business Research Company, the CRISPR market is expected to reach $1.55 billion in 2023.
Susceptibility to Covid-19 might be influenced by genetic variants of the FURIN gene that encodes a protein critical for viral infection. That was concluded from a study where CRISPR was used to introduce genetic variation.